FDAClass IIIRecall started August 27, 2026

Olanzapine Tablets 5 mg Recall: Impurity Out of Spec

Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods…

Why was Olanzapine Tablets 5 mg recalled?

Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot: BOB22321A, Exp 07-31-2027.

Product
Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods…
Recalling firm
Macleods Pharmaceuticals Limited
Quantity
22,032 30-count bottles
Distribution
Nationwide in the USA
Recall started
August 27, 2026
Report date
September 30, 2026
Classification
Class III
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls